Page last updated: 2024-09-05

regadenoson and Astrocytoma, Grade IV

regadenoson has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anders, NM; Figg, WD; George, RT; Gilbert, M; Grossman, SA; Harfi, TT; Jackson, S; McAreavey, D; Nduom, EK; Peer, C; Rudek, MA; Weingart, J; Ye, X	1

Trials

1 trial(s) available for regadenoson and Astrocytoma, Grade IV

Article	Year
The effect of an adenosine A Fluids and barriers of the CNS, 2018, Jan-15, Volume: 15, Issue:1 Topics: Adenosine A2 Receptor Agonists; Administration, Intravenous; Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Purines; Pyrazoles; Receptor, Adenosine A2A; Temozolomide	2018

Article

Year

The effect of an adenosine A

Fluids and barriers of the CNS, 2018, Jan-15, Volume: 15, Issue:1

Topics: Adenosine A2 Receptor Agonists; Administration, Intravenous; Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Purines; Pyrazoles; Receptor, Adenosine A2A; Temozolomide

2018